DNA-LIPOSOME VERSUS ADENOVIRAL MEDIATED GENE TRANSFER OF TRANSFORMING GROWTH FACTOR??1 IN VASCULARIZED CARDIAC ALLOGRAFTS: DIFFERENTIAL SENSITIVITY OF CD4+ AND CD8+ T CELLS TO TRANSFORMING GROWTH FACTOR??11
- 1 November 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 70 (9) , 1292-1301
- https://doi.org/10.1097/00007890-200011150-00006
Abstract
We have developed a model of transforming growth factor (TGF)β1 gene transfer into mouse vascularized cardiac allografts to study the use of gene transfer as an immunosuppressive therapy in transplantation. Donor hearts were perfused with either DNA-liposome complexes or adenoviral vectors that encode the active form of human TGFβ1. DNA-liposome mediated transfection prolonged allograft survival in approximately two-thirds of transplant recipients, while adenoviral delivery of TGFβ1 was not protective. Protective TGFβ1 gene transfer was associated with reduced Th1 responses and an inhibition of the alloantibody isotype switch. The protective effects of TGFβ1 gene transfer were overridden by exogenous interleukin-12 administration. Interestingly, alloreactive CD4+ and CD8+ cells exhibited distinct sensitivities to TGFβ1 gene transfer: CD4+ Th1 function was abrogated by this modality, although CD8+ Th1 function was not. Transient depletion of recipient CD8+ cells markedly prolonged the survival of grafts transfected with either DNA-liposome complexes or adenoviral vectors. Transgene expression persisted for at least 60 days, and Th1 responses were not detectable until CD8+ T cells repopulated the periphery. However, long-term transfected allografts appeared to exhibit exacerbated fibrosis and neointimal development. These manifestations of chronic rejection were absent in long-term transfected isografts, suggesting that long-term expression of active TGFβ1 alone is not sufficient to induce fibrosis of the grafts. Collectively, these data illustrate the utility of immunosuppressive gene therapy as a treatment for transplantation when combined with additional conditioning regimens. Further, they illustrate that alloreactive CD4+ and CD8+ cells may be differentially influenced by cytokine manipulation strategies.Keywords
This publication has 50 references indexed in Scilit:
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- ARE Th2 HELPER T LYMPHOCYTES BENEFICIAL, DELETERIOUS, OR IRRELEVANT IN PROMOTING ALLOGRAFT SURVIVAL?1Transplantation, 1997
- Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammationImmunology Today, 1997
- FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1995
- Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsivenessTransplant Immunology, 1995
- EVIDENCE THAT LONG-TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI-CD4 MONOCLONAL ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T CELLSTransplantation, 1992
- CELLS MEDIATING ALLOGRAFT REJECTIONTransplantation, 1991
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987
- WHICH T CELLS MEDIATE ALLOGRAFT REJECTION?Transplantation, 1985